Table 2 Prognostic factors for estimated 4 year recurrence free survival
Prognostic factors | Recurrence free survival (%) | P value | |
|---|---|---|---|
Milan criteria | In | 89 | < 0.0001 |
out | 53 | ||
UCSF criteria | In | 85 | 0.02 |
out | 54 | ||
Number of tumors | ≤3 | 82 | 0.2 |
> 3 | 46 | ||
Size of largest tumor (cm) | ≤ 5 | 82 | 0.004 |
> 5 | 62 | ||
AFP (ng/ml) | < 600 | 83 | < 0.0001 |
> 600 | 30 | ||
< 1000 | 79 | < 0.0001 | |
> 1000 | 45 | ||
< 2000 | 78 | < 0.0001 | |
> 2000 | 41 | ||
Grade | Well/moderate | 85 | 0.008 |
poor | 61 | ||
Microvascular invasion | Absent | 90 | < 0.0001 |
present | 49 | ||
Pretransplant treatment | Not received | 86 | 0.01 |
received | 54 | ||
Graft to recipient weight ratio | > 0.8 | 80 | 0.1 |
< 0.8 | 74 | ||
CTP class | A | 82 | 0.3 |
B | 73 | ||
C | 84 | ||
MELD score | < 20 | 80 | 0.6 |
> 20 | 77 |